MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan
Date：0000-00-00Source: AmoyDx
Recommend
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
27 /03
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
24 /03
Career Opportunities - Business Manager (EMEA)
25 /11
Career Opportunities - The Field Application Scientist
25 /11
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS® (Sotorasib)
17 /11